Geneva's Spineart Receives 510(k) Clearance for SCARLET AC-Ti ‘Anterior Cervical Cage’

Spineart, a fast-growing company specialized in spine surgery, announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCARLET AC-Ti secured anterior cervical cage.

The SCARLET AC-Ti introduces features such as the MIMETIX morphometric profile, developed with digital models of the vertebrae to optimize the contact surface between implant and endplates. The system allows for fixation with screws and anchors.

The SCARLET AC-Ti cervical cage utilizes Spineart's proprietary Ti-LIFE technology. Ti-LIFE technology, a proprietary additive manufacturing process, has a porous structure that closely mimics the trabecular bone structure. "This approval underscores our commitment to innovation, continuously evolving our most successful products, such as the SCARLET system," said Alessia Erlingher, Chief Commercial Officer at Spineart.